Table 1 Clinical endpoints and model type
sTumor type | Description | Type of outcome |
|---|---|---|
Neuroblastoma | 5-year mortality risk | Binary |
Neuroblastoma | Relapse/progression risk | Binary |
Neuroblastoma | Time-to-death | Time-to-event |
HR-Neuroblastoma | HR 5-year mortality risk | Binary |
HR-Neuroblastoma | HR 5-year relapse/progression risk | Binary |
HR-Neuroblastoma | HR-time to relapse/progression | Time-to-event |
DIPG | 1-year mortality risk | Binary |
DIPG | 2-year mortality risk | Binary |
DIPG | 1-year progression risk | Binary |
DIPG | Time-to-death | Time-to-event |
DIPG | Time-to-progression | Time-to-event |